Refine by
Radiopharmaceutical Equipment & Supplies
49 equipment items found
Manufactured by:Advanced Accelerator Applications SA based inRueil-Malmaison Cedex, FRANCE
cGMP produced Lutetium-177, a radiopharmaceutical ...
Manufactured by:3B Pharmaceuticals GmbH based inBerlin, GERMANY
Radiopharmaceuticals are unique medicinal formulations containing radioisotopes which are used in major clinical areas for diagnosis and/or therapy. Targeted radiopharmaceuticals bind to specific structures such as proteins or cells within the body and thus accumulate in particular places, such as e.g. tumor lesions in a cancer ...
Manufactured by:Von Gahlen Nederland B.V. based inZevenaar, NETHERLANDS
Radiation-safe packaging is an obvious requirement during the transport of radioactive pharmaceuticals. Von Gahlen is your reliable partner in the production and worldwide supply of radiopharmaceutical packaging for shipping by road or air. We offer both standard and tailor-made packaging ...
by:Pars Isotope Co based inTehran, IRAN
FDG, or Fluoro Deoxy Glucose, is a pivotal radiopharmaceutical utilized in positron emission tomography (PET) imaging. This compound capitalizes on the principle of metabolic trapping to use a radioactive tracer to directly evaluate the body's metabolic functions. FDG's utilization in whole-body PET imaging substantially enhances the capabilities for cancer diagnosis and staging, ...
Manufactured by:ITM Isotope Technologies Munich SE based inGarching / Munich, GERMANY
Fully integrated HPLC configuration for radiopharmaceutical analysis: For research and GMP-compliant quality control. The Quality Control Solution radio-HPLC is a state-of-the-art configuration for the analysis of radiolabeled biomolecules according to Ph. Eur./USP standards. With an integrated quaternary HPLC pump, UV/VIS and radiodetectors, together with the latest Chromstar ...
Manufactured by:Tema Sinergie S.p.A. based inFaenza (Ra), ITALY
RAD-INJECT is the answer to the operator’s need for radioprotection during the radiopharmaceutical injection ...
Manufactured by:3B Pharmaceuticals GmbH based inBerlin, GERMANY
3B Pharmaceuticals (3BP) is a leading developer of targeted molecular radiopharmaceuticals focusing on cancer indications with high medical need. The focus of our drug development programs is a theragnostic approach using diagnostic imaging to identify patients who are likely responders to radiopharmaceutical therapy. 3BP has built a unique technology platform ...
by:Pars Isotope Co based inTehran, IRAN
The PARS-LUTOPSMA kit is an innovative theranostic radiopharmaceutical developed by Parsisotope Company, designed specifically for the treatment of metastatic prostate cancer. This kit is notable for being the first of its kind globally, and is used in conjunction with the Lu-177 radioisotope. It targets prostate-specific membrane antigen (PSMA), a membrane glycoprotein, the ...
by:Pars Isotope Co based inTehran, IRAN
Lu-177-PSMA is a theranostic radiopharmaceutical designed for the treatment of metastatic prostate cancer. Employing the Peptide Receptor Radionuclide Therapy (PRRT) technique, it selectively targets and binds to prostate tumor cells, facilitating the destruction of malignant cells. ...
by:Edinburgh Molecular Imaging based inEdinburgh, UNITED KINGDOM
Edinburgh Molecular Imaging has a portfolio of agents designed to improve detection and treatment of Cancer. All Agents progressed to date have been found to be safe, specific, sensitive and ...
Manufactured by:ITM Isotope Technologies Munich SE based inGarching / Munich, GERMANY
Active substance: no-carrier-added (n.c.a.) lutetium-177 (177Lu) ...
by:Pars Isotope Co based inTehran, IRAN
The PARS-LUTOTATE theranostic radiopharmaceutical kit is an innovative solution formulated as a single vial for the effective treatment of neuroendocrine tumors. It utilizes the Lu-177 radioisotope, enabling the radiopharmaceutical to selectively target neuroendocrine tumor cells, facilitating their complete destruction. ...
Manufactured by:Artemis Shielding based inFort Payne, ALABAMA (USA)
Transport containers from Artemis Shielding provide safe transportation of radioactive medical isotopes. Our containers are available for TC-99m, In-111, Ra-223, TI-201, I-123. We offer shielding for single-dose syringe (10cc) and blood vial cases. Like all Artemis Shielding products, the transport containers are non-toxic, lead-free, Prop 65 and RoHS ...
Manufactured by:ITM Isotope Technologies Munich SE based inGarching / Munich, GERMANY
Ready-to-use Radiopharmaceutical for Diagnosis & Staging of Neuroendocrine Tumors (NETs) ...
Manufactured by:Tema Sinergie S.p.A. based inFaenza (Ra), ITALY
DHC is a GMP grade A shielded isolator, with vertical laminar flow all over the working area, dedicated to radiopharmaceuticals dispensing processes in a controlled and safe environment. DHC was first conceived to provide the most relevant radiopharmaceutical companies a total laminar flow dispensing shielded isolator compliant with the latest GMP, USP and FDA ...
Manufactured by:Isotopia Molecular Imaging based inPetah Tikva, ISRAEL
Kit for Radiopharmaceutical preparation of Technetium Tc 99m Succimer ...
Manufactured by:Isotopia Molecular Imaging based inPetah Tikva, ISRAEL
Kit for Radiopharmaceutical preparation of Technetium Tc 99m Mertiatide ...
Manufactured by:Isotopia Molecular Imaging based inPetah Tikva, ISRAEL
Kit for Radiopharmaceutical preparation of Technetium Tc 99m Etifenin injection (for Hepatobiliary function ...
Manufactured by:Nuclidium AG based inBasel, SWITZERLAND
The platform features several advantageous properties such as favorable dosimetry, high imaging quality, and reduced radiation burden, which are crucial in detecting small metastases. Furthermore, the efficient production and supply chain of these copper-based radiopharmaceuticals enhance treatment accessibility worldwide, as no nuclear reactors are required, and radioactive ...
Manufactured by:Blue Earth Diagnostics based inOxford, UNITED KINGDOM
Diagnostic nuclear medicine is a type of molecular imaging that uses very small amounts of radioisotopes attached to a targeting molecule (radiopharmaceutical1) to diagnose complex diseases such as cancer. Radiopharmaceuticals are able to show the physiological function of the body rather than just the anatomy. Changes in the biochemical activity of cells often characterises ...